Skip to main content
Clinical Trials/NCT06184997
NCT06184997CompletedNot Applicable

Effect of a Sugar-free Isotonic Drink on Different Health Bioparameters

University of Alicante1 site in 1 country240 target enrollmentStarted: January 8, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
240
Locations
1
Primary Endpoint
Minerals in urine

Study Overview

Brief Summary

Randomized clinical trial in which 160 participants (80 men, 80 women) will be assigned to one of two groups (40 participants per group), to determine the effects of isotonic drink on different health parameters, following published recommendations. Subjects will be electronically randomized by block design into two arms: an experimental group: isotonic drink and a control group (placebo): normal water.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Outcomes Assessor)

Masking Description

Participants will not be aware that there are other people consuming a different type of drink than theirs. The person analyzing the results will also be unaware. However, the researchers will be aware because they need to control the supply.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •men and women aged >18 years;
  • •body mass index (BMI) of 18 to 25 kg/m^2;

Exclusion Criteria

  • •individuals who have taken medication up to 3 months before the start of the study or supplements during the study;
  • •individuals with a history of gastrointestinal pathology or disorder such as duodenal ulcer, chronic colitis, or chronic inflammatory disease/surgery of the gastrointestinal tract (Crohn's disease, ulcerative colitis), celiac disease, or irritable bowel syndrome;
  • •individuals with serious acute or chronic diseases, treatments, or recent surgery;
  • •individuals with a report of serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), or gamma-glutamyl transferase (GGT) above the upper limit of the reference interval.

Arms & Interventions

CONTROL GROUP

Placebo Comparator

Volunteer participants who will drink water

Intervention: PLACEBO (Other)

ISOTONIC DRINK GROUP

Experimental

Volunteer participants who will drink Natural isotonic drink based on 20% Atlantic sea water, mixed with lemon and stevia.

Intervention: INTAKE OF ISOTONIC DRINK (Other)

Outcomes

Primary Outcomes

Minerals in urine

Time Frame: 12 weeks

K+ (Potassium), Na+ (Sodium), Mg2+ (Magnesium), Ca2+ (Calcium)

Perceived stress

Time Frame: 12 weeks

Measurement of perceived stress using the Perceived Stress Scale (PSS)

Body composition

Time Frame: 12 weeks

Measurement of body composition using bioimpedance with the Biodyxpert device.

Specific gravity of urine

Time Frame: 12 weeks

Blood pressure

Time Frame: 12 weeks

Measurement of systolic and diastolic blood pressure. Using an OMROM upper arm blood pressure monitor.

BLOOD GLUCOSE

Time Frame: 12 weeks

Glucose levels in blood by blood analysis.

Specific color of urine

Time Frame: 12 weeks

Urinary pH

Time Frame: 12 weeks

Evaluation of the quality of life of patients with constipation (PAC-QOL)

Time Frame: 12 weeks

The PAC-QOL (Patient Assessment of Constipation Quality of Life) questionnaire is a specialized tool designed to assess the quality of life in individuals suffering from constipation. It is a patient-reported outcome measure that focuses on how constipation affects a person's daily life, well-being, and overall health.

Perception of quality of life

Time Frame: 12 weeks

Using a Quality of Life Questionnaire (SF36). Quality of Life Questionnaire is a comprehensive questionnaire that covers various attributes of an individuals life. It covers a variety of demographic questions to get better quality data and information before analyzing the quality of life of an individual.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

Mood States Profile

Time Frame: 12 weeks

The POMS (Profile of Mood States) questionnaire is a psychological assessment tool widely used to measure mood states. It consists of a series of words or phrases that describe feelings and emotions. Participants are asked to rate each item on a scale, indicating how well it represents their mood over a specific period. The POMS measures six different mood dimensions: Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-Inertia, and Confusion-Bewilderment. It's commonly used in clinical settings, as well as in research studies, to assess the impact of various treatments or interventions on mood states. The POMS is valued for its sensitivity in detecting mood changes over time and its ability to differentiate between various mood states.

BLOOD INSULIN

Time Frame: 12 weeks

Insulin levels in blood by blood analysis.

BLOOD LIPID PORFILE

Time Frame: 12 weeks

Cholesterol and triglycerides levels in blood.

Evaluation of constipation symptoms by the patient

Time Frame: 12 weeks

The PAC-SYM (Patient Assessment of Constipation Symptoms) is a self-report questionnaire designed to evaluate the symptoms of constipation from the patient's perspective. It is commonly used in clinical research and practice to assess the severity and impact of constipation symptoms. The questionnaire includes a series of items that ask patients to rate the frequency and severity of their constipation-related symptoms, such as abdominal discomfort, straining, and incomplete bowel movements.

Microbiome Indices

Time Frame: 12 weeks

Microbiome indices through stool sample; Firmicutes/Bacteroidetes, Bacteroides/Prevotella, Enterobacteria/Enterococcus, Clostridium coccoides/perfringens

Sleep quality

Time Frame: 12 weeks

Measurement of sleep quality using the Pittsburgh sleep quality index.

Liver biomarkers

Time Frame: 12 weeks

Measurement of liver biomarkers through a blood test; Aspartate aminotransferase (AST or GOT), Alanine aminotransferase (ALT or GPT) and Bilirubin

Secondary Outcomes

  • Weight(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Alejandro Martínez-Rodríguez

Full professor

University of Alicante

Study Sites (1)

Loading locations...

Similar Trials

Effect of a Sugar-free Isotonic Drink on... | Clinical Trial